First, such a drug would have to be given in conjunction with antibiotics, with which its half-life and other pharmacological properties would have to be compatible. Second, the gene responsible for the mutation-inducing mechanism could turn out to vary among bacteria. This is especially likely since this gene is not essential for bacterial survival, making variations among organisms more likely to persist.